Literature DB >> 8055199

Impaired lipoprotein metabolism in patients with primary gout--influence of alcohol intake and body weight.

S Takahashi1, T Yamamoto, Y Moriwaki, Z Tsutsumi, K Higashino.   

Abstract

Using logistic regression analysis, we investigated whether or not excessive alcohol intake and increased BMI, both of which are known causes of lipid metabolism abnormality, are associated with increased serum triglyceride, apolipoprotein B concentrations and decreased high-density lipoprotein cholesterol (HDL-C), high-density lipoprotein 2 cholesterol (HDL2-C) levels in patients with gout. Serum triglyceride levels were significantly higher in patients with gout than in normal subjects. In contrast, serum levels of HDL-C and HDL2-C were significantly lower in patients with gout than in normal subjects. These results were further analysed using stepwise logistic regression. This analysis demonstrated that both serum triglyceride levels and alcohol consumption discriminated subjects with gout from controls but BMI, HDL-C and HDL2-C did not, suggesting that increased serum triglyceride levels exist intrinsically in gout, while decreased concentrations of HDL-C and HDL2-C may be attributed to hypertriglyceridaemia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8055199     DOI: 10.1093/rheumatology/33.8.731

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  10 in total

1.  Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study.

Authors:  P H Dessein; E A Shipton; A E Stanwix; B I Joffe; J Ramokgadi
Journal:  Ann Rheum Dis       Date:  2000-07       Impact factor: 19.103

2.  Gout in males: a possible role for COMT hypomethylation.

Authors:  Xiuru Ying; Yanfei Chen; Zhonghua Zheng; Shiwei Duan
Journal:  Clin Rheumatol       Date:  2019-06-04       Impact factor: 2.980

3.  Serum urate is not associated with coronary artery calcification: the NHLBI Family Heart Study.

Authors:  Tuhina Neogi; Robert Terkeltaub; R Curtis Ellison; Steven Hunt; Yuqing Zhang
Journal:  J Rheumatol       Date:  2010-10-01       Impact factor: 4.666

4.  Prevalence of hyperuricemia in Bangkok population.

Authors:  Somchai Uaratanawong; S Suraamornkul; S Angkeaw; R Uaratanawong
Journal:  Clin Rheumatol       Date:  2011-02-08       Impact factor: 2.980

Review 5.  Impact of Statin Therapy on Plasma Uric Acid Concentrations: A Systematic Review and Meta-Analysis.

Authors:  Giuseppe Derosa; Pamela Maffioli; Željko Reiner; Luis E Simental-Mendía; Amirhossein Sahebkar
Journal:  Drugs       Date:  2016-06       Impact factor: 9.546

6.  Apolipoprotein E phenotypes in patients with gout: relation with hypertriglyceridaemia.

Authors:  Y Moriwaki; T Yamamoto; S Takahashi; Z Tsutsumi; K Higashino
Journal:  Ann Rheum Dis       Date:  1995-05       Impact factor: 19.103

7.  Correlation between Gout and Coronary Heart Disease in Taiwan: A Nationwide Population-Based Cohort Study.

Authors:  Kuang-Hua Huang; Chih-Jaan Tai; Ya-Fang Tsai; Yu-Hsiang Kuan; Chien-Ying Lee
Journal:  Acta Cardiol Sin       Date:  2019-11       Impact factor: 2.672

8.  New and improved strategies for the treatment of gout.

Authors:  Natalie Dubchak; Gerald F Falasca
Journal:  Int J Nephrol Renovasc Dis       Date:  2010-11-24

9.  Effect of fenofibrate in combination with urate lowering agents in patients with gout.

Authors:  You-Hyun Lee; Chan-Hee Lee; Jisoo Lee
Journal:  Korean J Intern Med       Date:  2006-06       Impact factor: 2.884

10.  Potential of IL-33 for Preventing the Kidney Injury via Regulating the Lipid Metabolism in Gout Patients.

Authors:  Lihua Duan; Yan Huang; Qun Su; Qingyan Lin; Wen Liu; Jiao Luo; Bing Yu; Yan He; Hongyan Qian; Yuan Liu; Jie Chen; Guixiu Shi
Journal:  J Diabetes Res       Date:  2016-08-07       Impact factor: 4.011

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.